Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Science Advances|April 12, 2024
Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejectionArianna Barbetta, Brittany Rocque, Sarah Bangerth, et al.
JAMA Network Open|October 9, 2025
Barriers and Facilitators of Treatment Intensification in Metastatic Castration-Sensitive Prostate CancerStacy Loeb, Neeraj Agarwal, Nader El-Chaar, et al.
Drug and Alcohol Dependence|December 11, 2017
Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescentsJanet Kim, Marilyn E Coors, Susan E Young, et al.
Cureus|June 22, 2026
Research Training of Future Leaders in Radiology: A Pilot International Outreach Educational ProgramAndrea S Doria, Jennifer R McKinney, Aleena Malik, et al.
Prostate Cancer and Prostatic Diseases|July 24, 2025
Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancerStephen J Freedland, Agnes Hong, Nader El-Chaar, et al.
Translational Andrology and Urology|March 14, 2022
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD®) in Asian men with prostate cancerRohan Malek, Sheng-Tang Wu, Dennis Serrano, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
A novel RNA nucleic acid amplification test more accurately distinguishes active Clostridioides difficile infection from colonizationKenneth D Long, Daniel J Silberger, John Hernandez, et al.
Future Oncology (London, England)|February 9, 2018
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPETScott C Flanders, Janet Kim, Samuel Wilson, et al.
Journal of Clinical Immunology|December 23, 2019
Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte PhenotypeElizabeth M Klinken, Paul E Gray, Bethany Pillay, et al.
Vaccines|April 17, 2020
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck CancerRamireddy Bommireddy, Luis E Munoz, Anita Kumari, et al.
Pageof 6